Goldman Sachs raised the firm’s price target on Imax (IMAX) to $18 from $17 and keeps a Sell rating on the shares. The firm notes the company reported Q2 results that were inline with consensus on Revenue and slightly above on company reported Adjusted EBITDA driven by operating leverage on higher revenues and continued execution against cost efficiencies.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX:
- Imax price target raised to $38 from $31 at Seaport Research
- Imax price target raised to $37 from $35 at Rosenblatt
- IMAX Corporation Reports Strong Q2 2025 Results
- IMAX Earnings Call Highlights Record Growth and Optimism
- IMAX’s Strong Market Position and Growth Prospects Justify Buy Rating and Raised Price Target